Bausch & Lomb Inc. (BOL-N) Stock Predictions - Stockchase
WATCH LIST
4
Bausch & Lomb Inc. (BOL-N)

ON STOCKCHASE SINCE May 2005

biotechnology/pharmaceutical

Bausch & Lomb Inc.

BOL-N

0 watching          
Join the Discussion

Bausch & Lomb Inc. (BOL-N) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about BOL-N



  • All
  • Filtered
Signal Opinion Expert
HOLD
Bausch & Lomb Inc.(BOL-N) 

April 26, 2007

Had a misstep on a contact lens solution and the stock dropped to the mid-$40's. He bought at that level, because even if all of their contact lens solution went to zero, they still had other businesses. Recent rumours have driven the stock up to $60.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Had a misstep on a contact lens solution and the stock dropped to the mid-$40's. He bought at that level, because even if all of their contact lens solution went to zero, they still had other businesses. Recent rumours have driven the stock up to $60.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Pat Naccarato

Vice Presi, AIC Limited...

Price Price
$59.510
Owned Owned
Yes

DON'T BUY
Bausch & Lomb Inc.(BOL-N) 

November 7, 2006

Have been under investigation by the FCC. Also had some product defect.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have been under investigation by the FCC. Also had some product defect.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ian Nakamoto

Director o, MacDougall, MacDouga...

Price Price
$52.500
Owned Owned
Unknown

DON'T BUY
Has never been a big fan of this company. Believes they had to restate some earnings which is what caused the stock price to dip.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has never been a big fan of this company. Believes they had to restate some earnings which is what caused the stock price to dip.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$44.680
Owned Owned
No

TOP PICK
Has gone through a transition. Was suffering a few years ago when it lost its momentum, R&D lagged. Can see some growth opportunity in their new lens. New president has shaken down the company, cut costs and re-invigorated their R&D. Has exceeded expectations for 13 quarters.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has gone through a transition. Was suffering a few years ago when it lost its momentum, R&D lagged. Can see some growth opportunity in their new lens. New president has shaken down the company, cut costs and re-invigorated their R&D. Has exceeded expectations for 13 quarters.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ian Ainsworth

Vice Presi, MacKenzie Financial ...

Price Price
$76.300
Owned Owned
Yes

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company